The hyaluronidases are a family of enzymes that degrade hyaluronic acid. Karl Meyer classified these enzymes in 1971 into three distinct groups, a scheme based on the enzyme reaction products. The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase. In humans, there are six associated genes, including HYAL1, HYAL2, HYAL3, and PH-20/SPAM1.

Hyaluronidase is an enzyme that is designed to break down the Hyaluronic acid gels that comprise dermal fillers such as Restylane, Perlane, Juvederm, Voluma, Belotero and others. With the surging demand of facial Hyaluronidase injection, the face-lift will play a crucial role to drive growth of Hyaluronidase, the research estimates Global Hyaluronidase Market Amounted to 2.28 $Billion at 7.33% CAGR over 2016-2020.

In addition, the Hyaluronidase can be used as a drug.
By catalyzing the hydrolysis of hyaluronan, a constituent of the extracellular matrix (ECM), hyaluronidase lowers the viscosity of hyaluronan, thereby increasing tissue permeability. It is, therefore, used in medicine in conjunction with other drugs to speed their dispersion and delivery. Common applications are ophthalmic surgery, in combination with local anesthetics. It also increases the absorption rate of parenteral fluids given by hypodermoclysis, and is an adjunct in subcutaneous urography for improving resorption of radiopaque agents. Hyaluronidase is also used for extravasation of hyperosmolar solutions.

Brand names of animal-derived hyaluronidase include HydaseTM (developed and manufactured by PrimaPharm Inc.), which has been FDA-approved as a “thimerosal-free” animal-derived hyaluronidase, Vitrase (Bausch + Lomb/Valeant Pharmaceuticals), Amphadase (Amphastar Pharmaceuticals), and Wydase. Wydase, however, is no longer manufactured.

Read Full Report: http://www.gosreports.com/global-hyaluronidase-market-research-report-2016/

The report firstly introduced Hyaluronidase basic information including Hyaluronidase definition classification application and industry chain overview; Hyaluronidase industry policy and plan, Hyaluronidase product specification, manufacturing process, cost structure etc. Then we deeply analyzed the world’s main region market conditions that including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.

In the end, the report introduced Hyaluronidase new project SWOT analysis, investment feasibility analysis, and investment return analysis and Global Hyaluronidase industry.

In a word, it was a depth research report on Global Hyaluronidase industry. And thanks to the support and assistance from Hyaluronidase industry chain related technical experts and marketing experts during Research Team survey and interviews.

The report including six parts, the first part manly introduced the product basic information; the second parts mainly analyzed the Asia Hyaluronidase industry; the third part mainly analyzed the North American Hyaluronidase industry; the fourth part mainly analyzed the Europe Hyaluronidase industry; the fifth part mainly analyzed the market entry and investment feasibility; the sixth part was the report conclusion chapter.

Joanna | Executive – International Business and partner Relations

E-mail: [email protected] | Tel: 510-400-8520

Web: www.gosreports.com